Predictive Value of Dimensional and Functional MRI Parameters on Mid-Treatment MRI for Pathologic Complete Response in Breast Cancer [0.03%]
乳腺癌新辅助治疗中期病理性完全缓解的磁共振影像预测参数研究
Ahmet Bozer,Levent Altın,Hamza Eren Güzel
Ahmet Bozer
Objective: To evaluate the predictive performance of dimensional and functional magnetic resonance imaging (MRI) parameters obtained from mid-treatment breast MRI for forecasting pathologic complete response (pCR) in pati...
Prognostic Performance of the Residual Cancer Burden Index With Respect to Molecular Breast Cancer Subtypes [0.03%]
残留癌症负荷指数对分子乳腺癌亚型预后价值的分析
Emanuelle Narciso Alvarez Valente,Anke Bergman,Marcelo Adeodato Belloa et al.
Emanuelle Narciso Alvarez Valente et al.
Objective: The use of neoadjuvant chemotherapy (NAC) has improved outcomes in breast cancer (BC). The residual cancer burden index (RCB) predicts prognosis. This study evaluated RCB as a prognosticator in BC subtypes trea...
Hemochromatosis: A Risk Factor for Breast Cancer? Systematic Review and Meta-Analysis [0.03%]
遗传性血色素沉着症与乳腺癌关系的系统评价和 meta 分析
Megane Buttignol,Caroline Bouche,Manon Chrétien et al.
Megane Buttignol et al.
Objective: Hereditary hemochromatosis and breast cancer are two major public health problems. The HFE gene variants C282Y and H63D, responsible for most cases of hemochromatosis, may contribute to carcinogenesis via iron ...
ROPN1 Gene Expression as a Prognostic and Predictive Biomarker in Aggressive Breast Cancer: Clinical Implications and Survival Association [0.03%]
ROPN1基因表达作为侵袭性乳腺癌预后和预测生物标志物的临床意义及生存关联研究
Ricardo Cesar Cintra,Andrés Galindo Céspedes,Olinda Maria Gamarra et al.
Ricardo Cesar Cintra et al.
Objective: The ropporin-1 (ROPN1) gene, initially linked to sperm motility, is differentially expressed in triple negative breast cancer (TNBC), suggesting a role in tumor progression and therapy resistance. To characteri...
Exploring Body Image Satisfaction in Post-Mastectomy Female Breast Cancer Patients [0.03%]
乳腺癌术后女性患者身体形象满足感调查研究
Rija Latifee,Usra Parvez,Shah Muhammad et al.
Rija Latifee et al.
Objective: Mastectomy is a widely used surgical intervention for breast cancer in Pakistan, where late-stage diagnoses are common and breast-conserving options are often limited. While effective oncologically, mastectomy ...
Accuracy of Intraoperative Sentinel Lymph Node Evaluation by Imprint Cytology in Breast Cancer: A 12-Year Single Center Experience With 2,528 Patients [0.03%]
乳腺癌术中印片细胞学评估前哨淋巴结的准确性：一项单中心12年经验（2528例患者）
Aysel Bayram,Sidar Bagbudar,Cagla Safak Karaoglan et al.
Aysel Bayram et al.
Objective: Sentinel lymph node biopsy (SLNB) is a key procedure for evaluating axillary lymph node status in early breast cancer, offering lower morbidity than axillary lymph node dissection. Intraoperative evaluation (IO...
Mammographic Breast Pseudocalcifications Associated With Topical Betamethasone Dipropionate [0.03%]
与外用倍他米松二丙酸酯相关的乳腺类钙化灶
Hayes Pearce,Jamie Spoont,Priscila Sanchez Aguirre et al.
Hayes Pearce et al.
Screening mammography plays a critical role in the early detection of breast cancer. Suspicious breast calcifications on mammography often prompt further diagnostic evaluation due to concern for malignancy, worrying physicians and patients ...
Reclassification of BRCA1 and BRCA2 Variants of Unknown Significance in a Turkish Cohort; A Single-Center, Retrospective Study [0.03%]
土耳其人群中BRCA1和BRCA2变异意义未知的再分类；一项单中心、回顾性研究
Leyla Özer,Süleyman Aktuna,Evrim Ünsal
Leyla Özer
Objective: Accurate classification of Breast cancer susceptibility gene (BRCA)1/2 variants is important to delineate candidates for surgical or medical treatment. We retrospectively analyzed BRCA1/BRCA2 sequencing data an...
Role of Radiotherapy in Elderly Patients (≥65 Years) With Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis [0.03%]
老年三阴性乳腺癌患者(≥65岁)放疗作用的系统评价和meta分析
Eran Sharon,Igor Snast,Rinat Yerushalmi et al.
Eran Sharon et al.
This is the first meta-analysis evaluating the benefit of adjuvant radiotherapy in older patients (≥65 years) with triple-negative breast cancer (TNBC). The medical literature was searched for all randomized controlled trials, nonrandomize...